tbuckley/cabot-search huggingface dataset:
Hydrocortisone or Placebo to Reduce Dexamethasone-Induced Neurobehavioral Side Effects: Results of a Phase 3 National, Double-Blind, Placebo-Controlled Randomized Trial with Crossover Design
Authors: Annelienke M. van Hulst, Erica L.T. van den Akker, Emma J. Verwaaijen, Marta Fiocco, Niki Rensen, Raphaële R.L. van Litsenburg, Saskia M.F. Pluijm, C. Michel Zwaan, Hanneke M. Van Santen, Rob Pieters, Andrea W.M. Evers, Martha A. Grootenhuis, Marry M. van den Heuvel-Eibrink
Journal: Blood (2022)
ECOG,β2-Microglobulin, Hemoglobin and Lactate Dehydrogenase Can Predict Early Grade ≥ 3 Infection Accurately in Patients with Newly Diagnosed Multiple Myeloma: A Real-World Study from China
Authors: Xinyi Lu, Xinyue Chen, Liping Yang, Qiong Yao, Jie Zhao, Shaolong He, Liangming Ma, Chunrui Li, JIA Wei, Weiwei Tian
Journal: Blood (2022)
Frailty and Sarcopenia within the Earliest Dutch Childhood Cancer Survivor Cohort (n=2,003): A Dccss-Later Study
Authors: Jenneke E. van Atteveld, Demi T.C. de Winter, Vincent G. Pluimakers, Marta Fiocco, Rutger A.J. Nievelstein, Monique G.G. Hobbelink, Leontien C.M. Kremer, Cécile M. Ronckers, Martha A. Grootenhuis, Heleen Maurice-Stam, Wim J.E. Tissing, Andrica C.H. de Vries, Jacqueline J. Loonen, Eline Van Dulmen-den Broeder, Helena J. van der Pal, Saskia Pluijm, Margriet van der Heiden-van der Loo, Birgitta Versluys, Marloes Louwerens, Dorine Bresters, Hanneke M. van Santen, Imo Hoefer, Sjoerd A.A. van den Berg, Jan H.J. Hoeijmakers, Sebastian J.C.M.M. Neggers, Marry M. van den Heuvel-Eibrink
Journal: Blood (2022)
Clinical, Molecular, and Histopathological Correlates in a Series of 24 Consecutive Cases of Suspected Myeloproliferative Neoplasms with a <i>JAK2</i>V617F Variant Allele Frequency ≤1%
Authors: Giuseppe Gaetano Loscocco, Raffaella Santi, Carmela Mannarelli, Francesco Mannelli, Francesca Gesullo, Giacomo Coltro, Paola Guglielmelli, Umberto Gianelli, Alessandro M Vannucchi
Journal: Blood (2022)
Tagraxofusp Administered Concomitantly with Intrathecal Chemotherapy in Patients with BPDCN who Either Have or are Considered High-risk to Develop CNS Disease is a Safe and Effective Treatment Strategy: An Italian Multicenter Experience
Authors: Giulia Rivoli, Germana Beltrami, Anna M. Raiola, Carole Paley, Marcello Riggi, Alida Dominietto, Emanuele Angelucci
Journal: Blood (2022)
Treatment Patterns and Outcomes in Lower-Risk, Non-Del(5q) Myelodysplastic Syndromes: Findings from a Global Real-World Medical Record Review Study
Authors: Maria Diez-Campelo, Aylin Yucel, Ravi K. Goyal, Rohan C. Parikh, Elizabeth Esterberg, Maria Jimenez, Martina Sluga-O'Callaghan, Dimana Miteva, Hong Xiao, Ulrich Germing
Journal: Blood (2022)
Thrombotic and Infectious Complications in Patients with Autoimmune Hemolytic Anemia: A Multicenter Observational Study
Authors: Bruno Fattizzo, Nicola Cecchi, Edoardo Tamellini, Francesca Morelli, Ilaria Tanasi, Maria Di Perna, Simona Raso, Angelo Gardellini, Dorela Lame, Marica Laurino, Olga Mulas, Antonello Rana, Paola Bianchi, Wilma Barcellini
Journal: Blood (2022)
Radiation Sparing Reduced Intensity Conditioning for Allogeneic Cell Transplantation in Patients with Dyskeratosis Congenita Comparable to Standard of Care: A Phase III Single Institution Trial
Authors: Marketa Dimitrov, Svatava Merkle, Gregory M. Vercellotti, Shernan G Holtan, Jakub Tolar, Christen L. Ebens
Journal: Blood (2022)
Comprehensive Analysis of TP53 and CD58 Mutations and Identification of Patients with Inferior Prognosis and Enhanced Immune Escape in Diffuse Large B Cell Lymphoma
Authors: Xianhuo Wang, Tingting Zhang, Yaxiao Lu, Yue Fei, Lanfang Li, Lihua Qiu, Zhengzi Qian, Shiyong Zhou, Kai Fu, Huilai Zhang
Journal: Blood (2022)
Molecular Profiling across Lymphoma Subtypes Using MSK-Impact Next Generation Sequencing
Authors: Connie Lee Batlevi, Esther Drill, Michelle Okwali, Ryan Ptashkin, Philip C Caron, Zachary D. Epstein-Peterson, Lorenzo Falchi, Audrey Hamilton, Paul A. Hamlin, Steven M. Horwitz, Andrew M. Intlekofer, William T. Johnson, Niloufer Khan, Anita Kumar, Jennifer Kimberly Lue, Matthew J. Matasar, Alison J. Moskowitz, Ariela Noy, Colette Owens, Maria Lia Palomba, David J. Straus, Santosha Vardhana, Andrew D. Zelenetz, Maria E. Arcila, Ahmet Dogan, Venkatraman Seshan, Gilles Salles, Ahmet Zehir, Anas Younes
Journal: Blood (2022)
Evaluation of the Path to Diagnosis and Time to Treatment in Patients with Light-Chain Amyloidosis Using the Komodo Claims Database
Authors: Julia Catini, Quan Doan, Jennifer Evans, Andrew Rava, Thomas Defay, Guillermo Del Angel, Megan Teynor, Candida Cristina Quarta, Mathew S. Maurer, Isabelle Lousada
Journal: Blood (2022)
Assessment of Durable Responses after Brexucabtagene Autoleucel (KTE-X19) in the ZUMA-2 Study in Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)
Authors: Javier Munoz, Patrick M. Reagan, Andre H. Goy, David B. Miklos, Dan Zheng, Xiang Fang, Rhine R. Shen, Rubina Siddiqi, Ioana Kloos, Marie José Kersten, Michael Wang
Journal: Blood (2022)
Human Bone Marrow Organoids Enable the Study of Hematopoietic Cell-Stromal Interactions and Support the Survival of Malignant Cells from Patients
Authors: Abdullah Khan, Antonio Rodriguez-Romera, Michela Colombo, Jasmeet S Reyat, Guanlin Wang, Wei Xiong Wen, Lauren C Murphy, Rebecca Ling, Natalina Elliott, Nikolaos Sousos, Samuel Kemble, Beata Grygielska, Christopher Mahoney, Andrew P. Stone, Adam P Croft, David Bassett, Gowsihan Poologasundarampillai, Adele K. Fielding, Emily A. Cutler, Anindita Roy, Sarah Gooding, Julie Rayes, Kellie Machlus, Bethan Psaila
Journal: Blood (2022)
A Phase 3 Double-Blind, Randomized, Placebo Controlled Study to Evaluate the Efficacy and Safety of AB-205 Plus Standard of Care (SOC) Versus Placebo Plus Standard of Care in Adults with Lymphoma Undergoing High-Dose Therapy and Autologous Hematopoietic Cell Transplantation (E-CELERATE) (NCT05181540) - Trials in Progress
Authors: Michael Scordo, Geoffrey Shouse, Luke Mountjoy, Jordan Gauthier, Bhagirathbhai Dholaria, Scott D. Rowley, Jeremy M. Pantin, Zachariah Defilipp, Monica Mead, Paul Finnegan
Journal: Blood (2022)
A Product of "Clash of Titans" or True Reflection of Disease Biology? Validation of 2022 WHO and ICC Classifications in a Large Dataset of Patients with Myelodysplastic Syndrome
Authors: Somedeb Ball, Avani M Singh, Najla Al Ali, Luis E. Aguirre, Akriti G Jain, Zaker I. Schwabkey, Sara M Tinsley-Vance, Onyee Chan, Andrew Kuykendall, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, David A. Sallman, Rami S. Komrokji
Journal: Blood (2022)
Proteogenomic Analysis of <i>SF3B1</i> <i>mut</i> CLL Reveals Altered Protein Signaling Cascades and Metabolomic Pathways
Authors: Susan Klaeger, Eugen Tausch, Binyamin A. Knisbacher, Annie Apffel, Karl R Clauser, Corinne Williams, Clary Clish, Laura Z. Rassenti, Thomas J. Kipps, Kirsten Fischer, Michael Hallek, Michael A Gillette, Donna S. Neuberg, Gad Getz, DR Mani, Stephan Stilgenbauer, Catherine J. Wu, Steven A Carr
Journal: Blood (2022)
<i>IRX3</i> Oncogene Activation in T-ALL through Enhancer Hijacking Caused By <i>fto</i> Intron 8 Deletions
Authors: Sunniyat Rahman, Nadine Farah, Jonas Demeulemeester, Joana R Costa, Gianna Bloye, David O'Connor, Rachael Pocock, Adam Turna, SooWah Lee, Adele K. Fielding, Juliette Roels, Małgorzata Dawidowska, Pieter Van Vlierberghe, Suzana Hadjur, Alejandro Gutierrez, Michelle A Kelliher, Simone Riva, Jim R. Hughes, James O.J. Davies, Peter Van Loo, Mark A. Dawson, Marc R. Mansour
Journal: Blood (2022)
Clinical Significance of IGH Clonality Analysis with RNA Sequencing in B-Cell Precursor Acute Lymphoblastic Leukemia
Authors: Yuta Katai, Tatsuya Kamitori, Hiroo Ueno, Ryo Akazawa, Kiyotaka Isobe, Itaru Kato, Toshihiko Imamura, Katsuyoshi Koh, Satoshi Saida, Junko Takita
Journal: Blood (2022)
Real-World Evidence (RWE) Studies Supported Hematologic Oncology United States Food and Drug Administration (US FDA) Approval: What Do They Look like?
Authors: Binglin Yue, Adam Greenbaum, Shaohui Sun, Enda Zhu, Shicheng Weng, Chenmu Du, Xiaojuan Zhang, Shanmei Liao
Journal: Blood (2022)
Prognostic Factors and Outcomes of Adolescent and Adult Burkitt Lymphoma and Leukemiafrom a Low-Middle Income Country: An Experience from Hematology Cancer Consortium
Authors: Manju Sengar, Anu Korula, Prasanth Ganesan, Akhil Rajendra, Hasmukh Jain, Prasanna Samuel, Jayachandran P K, Gaurav Prakash, M. Joseph John, Rasmi Palassery, Chandran K. Nair, Tanuja Shet, Sushil Selvarajan, Lingaraj Nayak, Parathan Karunakaran, Fouzia NA, Om Prakash, Bhausaheb Bagal, Nikita Mehra, Saranya Kumaran, Sridhar Epari, Jayshree Thorat, Venkatraman Radhakrishnan, Aby Abraham
Journal: Blood (2022)
Standardizing the Diagnostic and Therapeutic Approach to Newly Diagnosed Children with ITP: Prospective Data from the ITP Consortium of North America (ICON) Quality Improvement Initiative
Authors: Hannah Elkus, Rachael F. Grace, Taylah Buissereth, Carolyn Bennett, Stacey Rifkin-Zenenberg, Elizabeth R Gunn, Jeffrey D. Lebensburger, Pablo Angulo, Monica Davini, Alexander W. Rankin, Taizo A. Nakano, Corinna L. Schultz, Ashley Pinchinat, Kirsty Hillier, Sherif M. Badawy
Journal: Blood (2022)
The Menin Inhibitor SNDX-5613 (revumenib) Leads to Durable Responses in Patients (Pts) with <i>KMT2A</i>-Rearranged or <i>NPM1</i> Mutant AML: Updated Results of a Phase (Ph) 1 Study
Authors: Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio, Branko Cuglievan, Richard M. Stone, Martha L. Arellano, Michael J. Thirman, Manish R. Patel, David Dickens, Shalini Shenoy, Neerav Shukla, Galit Rosen, Rebecca G. Bagley, Michael L. Meyers, Kate Madigan, Peter Ordentlich, Yu Gu, Steven Smith, Gerard M. McGeehan, Eytan Stein
Journal: Blood (2022)
Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study
Authors: Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Paul Monach, Mary Brophy, Nhan V Do, Nikhil C Munshi
Journal: Blood (2022)
Hetrombopag Add to Porcine ATG and Cyclosporine for Aplastic Anemia: Early Outcomes of a Prospective Pilot Study
Authors: Wenrui Yang, Xin Zhao, Xu Liu, Youzhen Xiong, Huihui Fan, Guangxin Peng, Li Zhang, Jianping Li, Lei Ye, Kang Zhou, Yuan Li, Yang Yang, Yingchang Mi, Liping Jing, Fengkui Zhang
Journal: Blood (2022)
Study of Angiogenic Potential and Oxidative Metabolism in Mesenchymal Stromal Cells Derived from Shwachman-Diamond Syndrome Patients
Authors: Clarissa Gervasoni, Alice Martina Giussani, Nadia Bertola, Erica Dander, Andrea Biondi, Paola Corti, Piero Farruggia, Giuseppe Menna, Marco Cipolli, Valentino Bezzerri, Anna Pegoraro, Simone Cesaro, Carlo Dufour, Enrico Cappelli, Silvia Ravera, Giovanna D'Amico
Journal: Blood (2022)
The Menin Inhibitor Ziftomenib (KO-539) Synergizes with Agents Targeting Chromatin Regulation or Apoptosis and Sensitizes AML with MLL Rearrangement or NPM1 Mutation to Venetoclax
Authors: Johanna Rausch, Margarita M. Dzama, Nadezda Dolgikh, Hanna Stiller, Stephan Bohl, Catharina Lahrmann, Kerstin Kunz, Linda Kessler, Hakim Echchannaoui, Chun-Wei David Chen, Thomas Kindler, Francis Burrows, Matthias Theobald, Daniel Sasca, Scott A. Armstrong, Michael Kuehn
Journal: Blood (2022)
ETV6 Represses TNF during Stress Hematopoiesis and Regulates HSC Self Renewal
Authors: Mackenzie Bloom, Rebekah Baskin-Doerfler, Ninad Oak, Ruopeng Feng, Xujie Zhao, Chunliang Li, Patrick Ozark, Katherine Verbist, Alexa Stroh, Sabrin Albeituni, JaQuel Maise, Mitchell J. Weiss, Shannon McKinney-Freeman, Jun J.J. Yang, Kim E. Nichols
Journal: Blood (2022)
Negative Feedback Regulation of MAPK Signaling Is an Important Driver of CLL Progression
Authors: Lisa Brandmeier, Veronika Ecker, Martina Stumpf, Piero Giansanti, Aida Varela Moreira, Lisa Pfeuffer, Marcel Fens, Junyan Lu, Bernhard Küster, Thomas Engleitner, Simon Heidegger, Ingo Ringshausen, Thorsten Zenz, Clemens-Martin Wendtner, Markus Müschen, Jürgen Ruland, Maike Buchner
Journal: Blood (2022)
A Multicenter Study of Safety, Tolerability, and Effectiveness of Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia
Authors: Zain M Virk, Ellen Zhang, Josanna Rodriguez-Lopez, Alison Witkin, Alexandra Wong, Jay Luther, Angela Lin, Mingming Ning, Eric F. Grabowski, Eric Holbrook, Hanny Al-Samkari
Journal: Blood (2022)
MRD Status By Clonoseq ® Is a Poor Predictor of Long-Term Outcomes after Bispecific LV20.19 CAR T-Cell Therapy for Relapsed, Refractory B-Cell NHL
Authors: Fateeha Furqan, Timothy S. Fenske, Walter L. Longo, Bryon Johnson, Mehdi Hamadani, Nirav N. Shah
Journal: Blood (2022)
<i>SF3B1, RUNX1</i> and <i>TP53</i> Mutations Significantly Impact the Outcome of Patients with Lower-Risk Myelodysplastic Syndrome
Authors: Jose F. Falantes, Francisco J. Márquez-Malaver, Estrella Carrillo-Cruz, Rosario M Morales-Camacho, Concepción Prats-Martín, Teresa Caballero, Eduardo Rodriguez Arbolí, Ildefonso Espigado, Jose A. Perez-Simon
Journal: Blood (2022)
Digital Droplet (dd) Polymerase Chain Reaction (PCR) Assays Offer Limited Advantages over Conventional Reverse-Transcriptase Quantitative PCR (RT-qPCR) for the Prediction of Molecular Recurrence after Treatment Discontinuation in Chronic Myeloid Leukemia (CML): Results from the Destiny Study
Authors: Kathy Dominy, Matthew Salmon, Richard Szydlo, Chloe Hayden, Helen E White, Mary Alikian, Dragana Milojkovic, Mhairi Copland, Letizia Foroni, Nicholas C.P. Cross, Richard E Clark, Jane F. Apperley
Journal: Blood (2022)
Inherited Germline DNA Repair Gene Defects Are Prevalent Among Thai Patients with Myeloid Neoplasms
Authors: Sunisa Kongkiatkamon, Chupong Ittiwut, Thanawat Rattanathammethee, Wanna Chetruengchai, Kitsada Wudhikarn, Sirorat Kobbuaklee, Amornchai Suksusut, Pimjai Niparuck, Noppacharn Uaprasert, Suporn Chuncharunee, Udomsak Bunworasate, Kanya Suphapeetiporn, Ponlapat Rojnuckarin, Chantana Polprasert
Journal: Blood (2022)
Establishing an Easy-to-Use 3D BM Niche Model for the Co-Culture of Primary Bone Marrow Mesenchymal Stromal Cells (BM-MSC) with Hematopoietic Stem and Progenitor Cells (HSPC)
Authors: Frances E Lock, Alannah Wilson, Amanda Amoah, Sharon Gao, Carolina Tropini, Arefeh Rouhi, Florian Kuchenbauer
Journal: Blood (2022)
Outcomes of Second-Line (2L) Triplet+ Regimens in Patients with Relapsed/Refractory Multiple Myeloma (MM) Following Progression after First-Line (1L) Lenalidomide in the Connect® MM Disease Registry
Authors: Hans C. Lee, Rafat Abonour, Sikander Ailawadhi, Brian G.M. Durie, Cristina J. Gasparetto, James W. Hardin, Mohit Narang, James Omel, Robert M. Rifkin, Howard Terebelo, Kathleen Toomey, Lynne I. Wagner, Samantha Slaff, Dailan Danforth, Weiyuan Chung, Jasmeet Anand, Edward Yu, Derek Tang, Sundar Jagannath
Journal: Blood (2022)
Outcomes of Chronic Myeloid Leukemia with No Major Molecular Response within 2 Years of Tyrosine Kinase Inhibitor Therapy
Authors: Aram Bidikian, Hagop Kantarjian, Ghayas C. Issa, Farhad Ravandi, Guillermo Garcia-Manero, Gautam Borthakur, Tapan M. Kadia, Naval Daver, Nitin Jain, Naveen Pemmaraju, Courtney D. DiNardo, Fadi Haddad, Sherry A. Pierce, Elias Jabbour, Koji Sasaki
Journal: Blood (2022)
Bmf-500: An Orally Bioavailable Covalent Inhibitor of FLT3 with High Selectivity and Potent Antileukemic Activity in FLT3-Mutated AML
Authors: Brian Law, Tripta Rughwani, Tenley C. Archer, Lekha Kumar, Daniel Lu, Priyanka Somanath, Yan Ma, Xiaodong Wang, David Sperandio, Steve Morris, Thorsten Kirschberg, Mini Balakrishnan, Thomas Butler
Journal: Blood (2022)
Sphingomyelin and Phosphatidylserine Derived Compounds Found into RBCs of Two Unrelated Individuals with Idiopathic Erythrocytosis with Altered Hemoglobin (Hb) Function Properties and No Hemoglobinopathies - Preliminary Results
Authors: Susan Elisabeth Jorge, Monica PINHEIRO DE ALMEIDA Verissimo, Fernando Ferreira Costa, Maria de Fátima Sonati
Journal: Blood (2022)
Functional Disruption of TET2-Mediated Cytosine Oxidation in CAR-T Cells Using IDH1 Neomorph
Authors: Kunho Chung, Jie Xu, Yaroslav Kaminskiy, Hongxing Sun, Min-Soo Kim, Christopher Petucci, Tong Wang, Rahul M Kohli, J. Joseph Melenhorst
Journal: Blood (2022)
ASC4OPT: A Phase 3b Open-Label Optimization Study of Oral Asciminib in Chronic Myelogenous Leukemia in Chronic Phase Previously Treated with 2 or More Tyrosine Kinase Inhibitors
Authors: Massimo Breccia, Anna Turkina, Carla Boquimpani, Charles Chuah, Giora Sharf, Luigi Di Caprio, Matthias Hoch, Justin Yssel, Yifan Zhang, Andreas Hochhaus
Journal: Blood (2022)
A Phase I/II Study of Combination of Azacitidine, Venetoclax and Pevonedistat in Patients with Newly-Diagnosed Secondary Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) with Hypomethylating Agent (HMA) Failure
Authors: Faustine Ong, Guillermo Garcia-Manero, Guillermo Montalban-Bravo, Yesid Alvarado, Maro Ohanian, Marina Konopleva, Elias Jabbour, Nitin Jain, Gautam Borthakur, Courtney D. DiNardo, Naval Daver, Ghayas C. Issa, Koji Sasaki, Kelly S. Chien, Koichi Takahashi, Michael Andreeff, Muharrem Muftuoglu, Ricardo Delumpa, Ejiroghene Mayor, Christopher Loiselle, Lourdes Waller, Glenda Banks, Hagop Kantarjian, Jorge E. Cortes, Nicholas Short
Journal: Blood (2022)
Protocol and Primary Analysis of Lome: A Randomized Trial of Low- Versus Intermediate-Dose Immune Tolerance Induction with Recombinant Factor VIII (Omfiloctocog alfa, SCT800) in China
Authors: Zhengping Li, Guoqing Liu, Zhen Yingzi, Xiaoling Cheng, Zhenping Chen, Di Ai, Zekun Li, Jie Sun, Kun Huang, Runhui Wu
Journal: Blood (2022)
ATG-F Versus ATG-T for Graft Versus Host Disease Prevention in Allogeneic Stem Cell Transplantation: A Retrospective Comparative Study
Authors: Itay Falicovich, Boaz Nachmias, Eran Zimran, Adir Shaulov, Moshe E Gatt, Polina Stepensky, Sigal Grisariu Greenzaid, Batia Avni
Journal: Blood (2022)
Trial in Progress: Tagraxofusp-Based Therapy to Eradicate Measurable Residual Disease of Acute Myelogenous Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation
Authors: Daria Gaut, Caspian Oliai, Steven Tsai, Chi-Hong Tseng, Aaron C. Logan, Gary J. Schiller
Journal: Blood (2022)
Comparing Survival Outcomes of Autologous and Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed/Refractory Nodal Peripheral T-Cell Lymphoma
Authors: Yumeng Zhang, Jennifer Eatrides, Ashley Rose, Ling Zhang, Farhad Khimani, Aleksandr Lazaryan, Bijal D. Shah, Hayder Saeed, Michael D. Jain, Hien D. Liu, Frederick L. Locke, Javier Pinilla Ibarz, Jongphil Kim, Mohamed A. Kharfan-Dabaja, Ernesto Ayala, Lubomir Sokol, Taiga Nishihori
Journal: Blood (2022)
Prevalence of Monoclonal Gammopathy of Clinical Significance (MGCS) Among Patients with Monoclonal Gammopathies: Report from a Referral Center
Authors: Efstathios Kastritis, Foteini Theodorakakou, Despina Fotiou, Ioannis Ntanasis-Stathopoulos, Vasiliki Spiliopoulou, Panagiotis Malandrakis, Magdalini Migkou, Evangelos Eleutherakis Papaiakovou, Nikolaos Kanellias, Maria Gavriatopoulou, Evangelos Terpos, Meletios A. Dimopoulos
Journal: Blood (2022)
Better Prognosis of Dominant-Negative Type of <i>IKZF1</i> Deletion in <i>BCR-ABL-</i>positive Adult B-Cell Acute Lymphoblastic Leukemia
Authors: Hiroyuki Kimura, Masahiro Onozawa, Shota Yoshida, Naoki Miyashita, Shogo Takahashi, Shota Yokoyama, Toshihiro Matsukawa, Shinsuke Hirabayashi, Shinichi Fujisawa, Shuichi Ota, Daisuke Hidaka, Akio Mori, Takeshi Kondo, Yasutaka Kakinoki, Yutaka Tsutsumi, Satoshi Yamamoto, Takuto Miyagishima, Takahiro Nagashima, Makoto Ibata, Hajime Kobayashi, Yoshihito Haseyama, Katsuya Fujimoto, Toshimichi Ishihara, Hajime Sakai, Takanori Teshima
Journal: Blood (2022)
AG-946 Normalizes Glycolysis and Improves Red Cell Indices in a Humanized Sickle Cell Mouse Model
Authors: Rohitash Jamwal, Lily C. Wain, Christopher Copeland, Penelope A. Kosinski, Megan Wind-Rotolo, Ilya Gertsman, William Eaton, David M Bodine, Lenny Dang, Swee Lay Thein
Journal: Blood (2022)
Impact of Venetoclax Exposure on Clinical Efficacy and Safety in Biomarker-Selected Patients with Relapsed or Refractory Multiple Myeloma: Implication for Dose Selection
Authors: Mohamed A Badawi, Sheryl Coppola, Doerthe Eckert, Sathej Gopalakrishnan, Eva Doelger, Edyta Dobkowska, Shaji K Kumar, Weize Huang, Rajeev Menon, Ahmed Hamed Salem
Journal: Blood (2022)
Periosteal Skeletal Stem Cells Can Migrate into the Bone Marrow and Support Hematopoietic Regeneration
Authors: Kemi Akinnola, Tony Marchand, Shoichiro Takeishi, Maria Marianovich, Sandra Pinho, Thierry Lamy, Karin Tarte, Julien Saint-Vanne, Paul S. Frenette, Kira Gritsman
Journal: Blood (2022)
The Patient Experience with Belantamab Mafodotin: Perspectives of Patients Receiving Treatment in Clinical Trials and in the Real-World
Authors: Attaya Suvannasankha, Thomas W. LeBlanc, Julia R. Correll, Chloe Carmichael, Boris Gorsh, Mona Martin, Helen Kitchen, Laurie Eliason, Madeleine Thursfield, Natalie Boytsov, Eva Brown Hajdukova, Mary Beth Lewis, Christine Mackay, Prani Paka, Alicia O'Neill, Sue Perera, Shivaranjani Naine, Alexa Molinari, Maya Hanna, David Kleinman
Journal: Blood (2022)
Characterization of <i>TP53</i>-Mutated Myelodysplastic Syndromes and Impact of Allelic Status and Concurrent Cytogenetic Abnormalities on Survival Outcomes
Authors: Luis E. Aguirre, Najla Al Ali, Akriti G Jain, Onyee Chan, Somedeb Ball, Andrew Kuykendall, Kendra Sweet, Jeffrey E. Lancet, Eric Padron, Rami S. Komrokji, David A. Sallman
Journal: Blood (2022)
Patterns of Neuropathy in ALL Patients Treated with Vincristine Based Regimens with and without Tyrosine Kinase Inhibitors
Authors: Audrey M. Sigmund, Michelle Fullmer, Rina Li, Tracelyn Freeman, Bryant Clemons, Stefanie Quimjian, Heather Niccum Haag, Ai Ni, Shuiying Hu, Alice S. Mims, Gretchen A. McNally, Maryam Lustberg, Bhavana Bhatnagar
Journal: Blood (2022)
Supportive Care Strategies in Myelodysplastic Syndromes and Acute Myeloid Leukemia in Older Adults: A National Survey of Canadian Hematologists
Authors: Anna R. Blankstein, Nora Choi, Lee Mozessohn, David Sanford, Kristjan Paulson, Emily Rimmer, Donald S. Houston, Sylvain Lother, Asher Mendelson, Allan Garland, Ryan Zarychanski, Annette E. Hay, Rena Buckstein, Brett L. Houston
Journal: Blood (2022)
Management of Complications of BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review
Authors: Razwana Khanam, Saba Batool, Mohammed Musa Najmuddin, Rana Usman, Kiran Kuriakose, Arooj Ahmed, Mohammad Ebad Ur Rehman, Zinath Roksana, Faiz Anwer
Journal: Blood (2022)
Efficacy and Safety of Emicizumab Prophylaxis in Patients with Acquired Hemophilia a Who Were Deemed Ineligible for Immunosuppressive Therapy: Additional Data from the Ageha Study
Authors: Hidekazu Nishikii, Nobuaki Suzuki, Ryota Kobayashi, Narumi Mizuno, Ryoto Ozaki, Midori Shima
Journal: Blood (2022)
Endogenous Thrombin Generation Potential in Patients with Pulmonary Embolism and Its Relevance to Thrombo-Inflammatory Biomarkers
Authors: Nusrat Jabeen, Fakiha Siddiqui, Amir Darki, Debra Hoppensteadt, Bulent Kantarcioglu, Mushtaq Hussain, Manuel Monreal, Jawed Fareed
Journal: Blood (2022)
Brexucabtagene Autoleucel for Relapsed/Refractory Mantle Cell Lymphoma: Real-World Outcomes in the United Kingdom
Authors: Maeve A O'Reilly, Robin Sanderson, William Wilson, David Burns, Caroline Besley, Thomas Creasey, Ben Uttenthal, Johnathon Elliot, Claire Roddie, Andrea Kuhnl, Shankara Paneesha, Frances Seymour, Sunil Iyengar, Lourdes Rubio, Matthew Wilson, Stephen Boyle, Kathleen PL Cheok, Graham P. Collins, Rod Johnson, Andrew K. McMillan
Journal: Blood (2022)
A Phase 1/2 Dose Escalation Study of the Myeloid Kinase Inhibitor HM43239 in Patients with Relapsed or Refractory Acute Myeloid Leukemia
Authors: Naval Daver, Kyoo Hyung Lee, Brian A. Jonas, Martha L. Arellano, Chul W. Jung, Sang Kyun Sohn, Sung-Soo Yoon, Jeong-Ok Lee, Jia Hu, Ranjeet Kumar Sinha, William G Rice, Rafael Bejar
Journal: Blood (2022)
Stromal Cell-Activated Bone Marrow Neutrophils Provide BAFF in Newly Diagnosed and Treated Multiple Myeloma
Authors: Madelon M.E. de Jong, Cathelijne Fokkema, Natalie Papazian, Teddie van Heusden, Michael Vermeulen, Sabrin Tahri, Remco Hoogenboezem, Mark van Duin, Pieter van de Woestijne, Anton Langerak, Annemiek Broijl, Pieter Sonneveld, Tom Cupedo
Journal: Blood (2022)